Safety of REL-1017 for Major Depressive Disorder

NCT04855760 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
627
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Relmada Therapeutics, Inc.